Skip to content
Black Friday — 30% OFFFree shipping on orders of $99 or more
  1. Home
  2. Cognitive Health & Nootropics
  3. Noopept (Omberacetam), (30mg/capsule), 60 Capsules
Cognitive Health

Noopept (Omberacetam), (30mg/capsule), 60 Capsules

Noopept (Omberacetam) is a synthetic dipeptide analog of the racetam family, known for its role in glutamatergic and cholinergic signaling pathways.

Presentation: Noopept (Omberacetam), (30mg/capsule), 60 Capsules.

Illustrative packaging generated with AI.

Original price was: $24.99.Current price is: $17.49.

Currently unavailable in the United States

Ask an advisor
An advisor contacts you and the partner pharmacy checks whether and how it can proceed. A valid prescription, or an assessment through an authorized telemedicine service, may be required.
  • Partner pharmacy
  • Personal assistance
  • Discreet delivery
  • Presentation
    Noopept (Omberacetam), (30mg/capsule), 60 Capsules

Shipping & Delivery

  • Normally dispatched within 24 hours of payment confirmation.
  • USPS Regular Shipping · $11.95 · Approx. 3–5 business days
  • FedEx 2 Days Delivery · $28.99 · Approx. 2 business days
  • FedEx Overnight Delivery · $40.99 · Approx. 1 business day

For laboratory research only.

Not for human or veterinary use.

Composition and product details

Overview

Noopept (Omberacetam) is a synthetic dipeptide analog of the racetam family, known for its role in glutamatergic and cholinergic signaling pathways. It exhibits high affinity for AMPA and NMDA receptors, contributing to its involvement in synaptic transmission and neurochemical interactions.

This compound undergoes rapid hydrolysis into bioactive peptide fragments, facilitating its metabolic activity. Noopept is processed through hepatic oxidation and conjugation, with primary clearance occurring via renal excretion.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Properties

Noopept (ethyl 1-(phenylacetyl)-L-prolylglycinate) is a synthetic dipeptide-derived small molecule and prodrug of cycloprolylglycine (cPG), an endogenous cyclic peptide. Following biotransformation, it yields cycloprolylglycine, a metabolite investigated for its interactions with glutamatergic signaling systems, including AMPA- and NMDA receptor-associated pathways. Experimental studies have also examined Noopept’s interactions with peptide-mediated regulatory mechanisms, receptor-associated signaling networks, and molecular communication pathways involved in signal transduction. Additional investigations have explored its effects on protein interaction systems, transcriptional regulation processes, and small molecule–peptide pharmacology. Research applications include AMPA/NMDA receptor pharmacology, glutamatergic signaling investigation, prodrug metabolism studies, cycloprolylglycine-related research, and mechanistic evaluation of receptor-associated regulatory systems. Supplied in 30 mg capsules. Independently third-party HPLC-tested; COA available per batch.

Research

HPLC Noopept Caps (6739 / M26AYNoo)
September 11, 2026

HPLC Noopept Caps (6739)
August 7, 2026

Capsule excipients are not specified in the available product documentation.